Login

Frédéric Gardès' Opening Speech at the Conference: 'Innovations for Smart Mobility | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unimot SA President Adam Sikorski Reflects on 2023 Achievements and Future Ambitions | Adam Sikorski, President, Unimot SA.
00:00:00
Corline Biomedical - Naventus Healthcare Summit, May 10, 2022 - Henrik Nittmar, CEO at Corline Biomedical
00:10:00
globally invests exclusively in early stage COSS|Joseph Jacks,General Partner,OSS Capital LP
00:10:00
Midnight Sun Mining: Developing Copper-Cobalt Deposits in Zambia
00:10:00
Inflation Updates and Fed Rate Expectations: Market Reactions and Upcoming Data | Rob McDougle, Vice-President, Zhang Financial.
00:10:00
Exploring Decision Diagnostics Corporation: A Potential Diamond in the Rough
00:10:00
Red Pine Exploration's Drilling and Growth Plans
00:10:00
Brief description by the CEO of Awardit AB | Erik Grohman, CEO, Awardit AB (publ) AWRD:STO
00:10:00
Forte Minerals CEO Patrick Elliott Discusses Copper and Gold Focus in Peru
00:10:00
In his interview on "Mad Money," Diebold Nixdorf CEO emphasized the company's focus on leveraging advanced technology to enhance banking and retail experiences, highlighting innovations such as seamless transactions and improved security measures​ ||Mr. O
00:10:00
Invest in the best early-stage technology companies before they become popular|Peter Livingston,Founder and General Partner,Unpopular Ventures
00:10:00
A financial advisor with Trustmark National Bank, providing expertise in investment strategies through Trustmark Investment Advisors, Inc.

© 2017 - Neuhu+